vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Lifeway Foods, Inc. (LWAY). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $55.4M, roughly 1.1× Lifeway Foods, Inc.). Lifeway Foods, Inc. runs the higher net margin — 4.6% vs -70.9%, a 75.5% gap on every dollar of revenue. On growth, Lifeway Foods, Inc. posted the faster year-over-year revenue change (18.0% vs 8.1%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-17.4M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 11.4%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
CTKB vs LWAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $55.4M |
| Net Profit | $-44.1M | $2.5M |
| Gross Margin | 52.9% | 27.8% |
| Operating Margin | -9.0% | 6.8% |
| Net Margin | -70.9% | 4.6% |
| Revenue YoY | 8.1% | 18.0% |
| Net Profit YoY | -557.1% | 1688.1% |
| EPS (diluted) | — | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $55.4M | ||
| Q3 25 | $52.3M | $57.1M | ||
| Q2 25 | $45.6M | $53.9M | ||
| Q1 25 | $41.5M | $46.1M | ||
| Q4 24 | $57.5M | $46.9M | ||
| Q3 24 | $51.5M | $46.1M | ||
| Q2 24 | $46.6M | $49.2M | ||
| Q1 24 | $44.9M | $44.6M |
| Q4 25 | $-44.1M | $2.5M | ||
| Q3 25 | $-5.5M | $3.5M | ||
| Q2 25 | $-5.6M | $4.2M | ||
| Q1 25 | $-11.4M | $3.5M | ||
| Q4 24 | $9.6M | $-160.0K | ||
| Q3 24 | $941.0K | $3.0M | ||
| Q2 24 | $-10.4M | $3.8M | ||
| Q1 24 | $-6.2M | $2.4M |
| Q4 25 | 52.9% | 27.8% | ||
| Q3 25 | 52.7% | 28.7% | ||
| Q2 25 | 52.3% | 28.6% | ||
| Q1 25 | 48.6% | 23.9% | ||
| Q4 24 | 58.5% | 25.3% | ||
| Q3 24 | 56.3% | 25.7% | ||
| Q2 24 | 54.6% | 27.0% | ||
| Q1 24 | 51.3% | 25.8% |
| Q4 25 | -9.0% | 6.8% | ||
| Q3 25 | -17.6% | 8.8% | ||
| Q2 25 | -23.3% | 10.8% | ||
| Q1 25 | -36.1% | 3.4% | ||
| Q4 24 | 5.2% | 1.5% | ||
| Q3 24 | -8.2% | 9.1% | ||
| Q2 24 | -18.3% | 11.0% | ||
| Q1 24 | -23.9% | 8.0% |
| Q4 25 | -70.9% | 4.6% | ||
| Q3 25 | -10.5% | 6.2% | ||
| Q2 25 | -12.2% | 7.9% | ||
| Q1 25 | -27.5% | 7.7% | ||
| Q4 24 | 16.8% | -0.3% | ||
| Q3 24 | 1.8% | 6.5% | ||
| Q2 24 | -22.4% | 7.7% | ||
| Q1 24 | -13.8% | 5.4% |
| Q4 25 | — | $0.15 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | — | $0.28 | ||
| Q1 25 | — | $0.23 | ||
| Q4 24 | — | $0.00 | ||
| Q3 24 | — | $0.19 | ||
| Q2 24 | — | $0.25 | ||
| Q1 24 | — | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $5.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $85.8M |
| Total Assets | $461.5M | $105.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $5.6M | ||
| Q3 25 | $93.3M | $23.0M | ||
| Q2 25 | $75.5M | $21.2M | ||
| Q1 25 | $95.3M | $19.4M | ||
| Q4 24 | $98.7M | $16.7M | ||
| Q3 24 | $162.3M | $20.6M | ||
| Q2 24 | $177.9M | $14.6M | ||
| Q1 24 | $168.8M | $12.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.5M |
| Q4 25 | $341.7M | $85.8M | ||
| Q3 25 | $378.6M | $82.8M | ||
| Q2 25 | $377.6M | $78.7M | ||
| Q1 25 | $379.6M | $74.2M | ||
| Q4 24 | $395.7M | $71.9M | ||
| Q3 24 | $385.5M | $71.5M | ||
| Q2 24 | $389.1M | $68.0M | ||
| Q1 24 | $392.6M | $63.5M |
| Q4 25 | $461.5M | $105.6M | ||
| Q3 25 | $494.9M | $109.5M | ||
| Q2 25 | $493.3M | $98.3M | ||
| Q1 25 | $482.6M | $93.7M | ||
| Q4 24 | $499.5M | $90.5M | ||
| Q3 24 | $491.2M | $91.3M | ||
| Q2 24 | $483.7M | $84.9M | ||
| Q1 24 | $492.1M | $82.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $267.0K |
| Free Cash FlowOCF − Capex | $-1.8M | $-17.4M |
| FCF MarginFCF / Revenue | -2.9% | -31.5% |
| Capex IntensityCapex / Revenue | 1.6% | 31.9% |
| Cash ConversionOCF / Net Profit | — | 0.11× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-16.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $267.0K | ||
| Q3 25 | $-3.9M | $6.9M | ||
| Q2 25 | $108.0K | $3.9M | ||
| Q1 25 | $-125.0K | $-150.0K | ||
| Q4 24 | $2.0M | $-2.6M | ||
| Q3 24 | $13.2M | $7.5M | ||
| Q2 24 | $6.2M | $6.5M | ||
| Q1 24 | $4.0M | $1.5M |
| Q4 25 | $-1.8M | $-17.4M | ||
| Q3 25 | $-4.6M | $1.8M | ||
| Q2 25 | $-1.5M | $1.6M | ||
| Q1 25 | $-974.0K | $-2.4M | ||
| Q4 24 | $1.1M | $-3.8M | ||
| Q3 24 | $12.2M | $5.9M | ||
| Q2 24 | $5.2M | $5.1M | ||
| Q1 24 | $3.4M | $-923.0K |
| Q4 25 | -2.9% | -31.5% | ||
| Q3 25 | -8.7% | 3.1% | ||
| Q2 25 | -3.2% | 3.0% | ||
| Q1 25 | -2.3% | -5.1% | ||
| Q4 24 | 1.9% | -8.2% | ||
| Q3 24 | 23.7% | 12.8% | ||
| Q2 24 | 11.0% | 10.4% | ||
| Q1 24 | 7.6% | -2.1% |
| Q4 25 | 1.6% | 31.9% | ||
| Q3 25 | 1.3% | 9.0% | ||
| Q2 25 | 3.5% | 4.3% | ||
| Q1 25 | 2.0% | 4.8% | ||
| Q4 24 | 1.6% | 2.7% | ||
| Q3 24 | 2.0% | 3.3% | ||
| Q2 24 | 2.3% | 2.9% | ||
| Q1 24 | 1.3% | 5.5% |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 1.96× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | — | -0.04× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 2.50× | ||
| Q2 24 | — | 1.73× | ||
| Q1 24 | — | 0.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
